Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optims: Optimizing IFN Beta-1b Dose in MS
NCT00473213Phase 3Completed
- Sponsor
- University of Turin
- Start
- Sep 1999
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of interferon beta-1b in multiple sclerosis (MS), sponsored by University of Turin. Started Sep 1999; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00473213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473213.